Stock Region Watchlist
Stock Region Weekly Watchlist - Friday, July 18, 2025
Stock Region Weekly Watchlist - Friday, July 18, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered financial advice. Always do your own research or consult with a financial advisor before making investment decisions.
Hello, Stock Region family!
It’s Friday, and you know what that means—time to dive into the latest market movers and shakers. This week’s watchlist is packed with exciting updates, from blockbuster earnings to game-changing acquisitions. Let’s break it down together, shall we?
Netflix ($NFLX)
Streaming giant with a flair for surprises
Netflix is on fire this week! The company crushed Q2 earnings expectations, reporting $7.19 per share (analysts were betting on $7.08). Revenue? A jaw-dropping $11.08 billion, up 16% year-over-year.
But wait, there’s more! Netflix upped its full-year revenue guidance to $44.8–$45.2 billion, thanks to booming ad sales and a surge in new members. Oh, and did I mention free cash flow skyrocketed 91% to $2.3 billion? That’s some serious cheddar.
What’s got me really excited, though, is their upcoming content lineup. “Wednesday” Season 2 and the “Stranger Things” finale? Yes, please! If you’re a Netflix bull, this might be your moment to shine.
American Express ($AXP)
The card that keeps on giving
AmEx is flexing its muscles with Q2 earnings of $4.08 per share, beating expectations of $3.89. Revenue climbed 9% to $17.9 billion, driven by—you guessed it—affluent cardholders who just can’t stop spending.
Here’s the kicker: AmEx is planning a major refresh of its Platinum cards later this year. They’re calling it their biggest card update ever. As someone who loves a good rewards program, I can’t wait to see what perks they roll out. If you’re holding AXP, this could be a rewarding ride (pun intended).
Chevron ($CVX)
Big moves in Big Oil
Chevron just wrapped up its acquisition of Hess Corporation, and wow, what a power play. This deal brings in top-tier assets like Guyana’s Stabroek Block and the U.S. Bakken shale. Translation? Chevron is setting itself up for massive free cash flow and production growth well into the 2030s.
Oh, and let’s not forget the $1 billion in annual cost savings they’re targeting by the end of 2025. If you’re an energy investor, Chevron’s long-term growth story is looking pretty compelling right now.
Sarepta Therapeutics ($SRPT)
Biotech with a bold vision
Sarepta is making waves with a strategic restructuring plan aimed at saving $400 million annually. Yes, it involves a 36% workforce reduction, but the company is laser-focused on its siRNA platform, which could revolutionize genetic therapies.
On the regulatory front, Sarepta resolved FDA concerns by agreeing to include a black box warning for its Duchenne muscular dystrophy gene therapy, ELEVIDYS. It’s a bittersweet win, but one that clears the path for future growth.
For the short-term traders out there, keep an eye on $17.10 for upside potential and $15.67 for downside risk. Sarepta is not for the faint of heart, but the rewards could be worth it.
And there you have it—this week’s watchlist! Whether you’re a growth investor, a dividend lover, or a biotech thrill-seeker, there’s something here for everyone.
What do you think of this week’s picks? Got a favorite stock or a hot take? Hit reply and let us know—we love hearing from you!
Until next time, happy investing!
— The Stock Region Team
Disclaimer: Stock Region does not provide personalized investment advice. All investments carry risk, and past performance is not indicative of future results.